1987 No. 1439

MEDICINES

The Medicines (Fees) Amendment Regulations 1987

Made

Laid before Parliament

Coming into force

The Secretary of State concerned with health in England, the Secretaries of State respectively concerned with health and with agriculture in Scotland and in Wales, the Minister of Agriculture, Fisheries and Food, the Department of Health and Social Services for Northern Ireland and the Department of Agriculture for Northern Ireland, acting jointly, with the consent of the Treasury, in exercise of powers conferred by section 1(1)(a) of the Medicines Act 19711 and now vested in them2 and of all other powers enabling them in that behalf, after consulting such organisations as appear to them to be representative of interests likely to be substantially affected by these Regulations pursuant to section 129(6) of the Medicines Act 19683, hereby make the following Regulations:

Citation, interpretation and commencement1

These Regulations, which may be cited as the Medicines (Fees) Amendment Regulations 1987, amend the Medicines (Fees) Regulations 19784 (hereinafter referred to as “the principal Regulations”) and shall come into force on 1st September 1987.

Insertion in the principal Regulations of regulation 4A2

After regulation 4 of the principal Regulations there is inserted the following regulation—

Capital fees for variations4A

1

Subject to the following provisions of this regulation a capital fee of £75 shall be payable by the applicant in connection with each application for the variation of one or more of the provisions of a product licence granted under Part II of the Act unless such application is made at the specific invitation of the licensing authority.

2

The provisions of paragraph (1) shall not apply in the case of an application for variation which is made by an authority or board constituted under the National Health Service Act 19775, the National Health Service (Scotland) Act 19786 or the Health and Personal Social Services (Northern Ireland) Order 19727

Amendment of regulation 14 of the principal Regulations3

In regulation 14 of the principal Regulations (time for payment of capital fees) there is inserted after the word “grant” the words “,or as the case may be, the variation,”.

Amendment to Table A of Part I of Schedule 1 to the principal Regulations4

1

Table A of Part I of Schedule 1 to the principal Regulations (types and levels of fees), is amended in accordance with the following provisions of this regulation.

2

For each entry in Column 2 (Capital Fees), of the sum “£2,500” there is substituted the sum “£4,000”.

3

For each entry in Column 2 of the sum “£150” there is substituted the sum “£250”.

Signed by authority of the Secretary of State for Social Services.

Tony NewtonMinister of State,Department of Health and Social Security
Wyn RobertsMinister of State for Wales
Ian LangMinister of State, Scottish Office

In Witness whereof the official seal of the Minister of Agriculture, Fisheries and Food is hereunto affixed on 10th August 1987.

John MacGregorMinister of Agriculture, Fisheries and Food

Sealed with the official seal of the Department of Health and Social Services for Northern Ireland this 6th day of August 1987.

G. BuchananUnder Secretary

Sealed with the official seal of the Department of Agriculture for Northern Ireland this 6th day of August 1987.

W. H. JackPermanent Secretary

We consent,

Peter LloydMichael NeubertTwo of Lords Commissioners of Her Majesty’s Treasury

(This note is not part of the Regulations)

These Regulations further amend the Medicines (Fees) Regulations 1978 (“the principal Regulations”) which provide for the fees payable in connection with licences granted and certificates issued under the Medicines Act 1968.

Regulation 2 introduces a capital fee of £75 for the variation of a product licence granted under Part II of the Medicines Act 1968. Only one fee is payable for an application to vary one or more of the provisions of a licence made on one occasion. Certain public bodies exempt from having to pay fees for the grant of a product licence under the principal Regulations are likewise exempted from having to pay this fee.

Regulation 3 provides that this fee be paid on the application for variation.

Regulation 4 amends Column 2 of Part I of Schedule 1 to the principal Regulations by increasing the amount of capital fees payable for the grant of product licences for medicinal products for human and veterinary use. The standard amount of capital fees payable is increased from £150 to £250 and the higher alternative amount (payable in circumstances specified in the principal Regulations) is increased from £2,500 to £4,000.